Cover Image
Market Research Report

Global Immuno-Oncology Market Size, Status and Forecast 2019-2025

Published by QYResearch Product code 760795
Published Content info 100 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Immuno-Oncology Market Size, Status and Forecast 2019-2025
Published: July 9, 2019 Content info: 100 Pages
Description

Immuno-Oncology (I-O) is an innovative area of research that seeks to help the body's own immune system fight cancer. The goal is to address the unmet need for long-term survival in patients with advanced cancers.

In 2018, the global Immuno-Oncology market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Immuno-Oncology status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immuno-Oncology development in United States, Europe and China.

The key players covered in this study

  • Amgen, Inc
  • AstraZeneca, Plc
  • Bristol-Myers Squibb
  • Celgene Corporation
  • Eli Lilly and Company
  • Merck & Co.
  • Hoffmann-La Roche AG
  • Johnson & Johnson
  • Novartis International AG
  • AbbVie
  • Pfizer Inc.
  • Sanofi S.A.
  • EMD Serono
  • Gilead Sciences Inc.
  • Prometheus Therapeutics & Diagnostics
  • Aduro BioTech
  • Galena Biopharma
  • Bavarian Nordic
  • Celldex Therapeutics
  • ImmunoCellular Therapeutics
  • Incyte

Market segment by Type, the product can be split into

  • Immune Checkpoint Inhibitors
  • Monoclonal Antibodies
  • Cytokine-Based Immunotherapy
  • Cancer Vaccines
  • CAR-T Cell Therapy

Market segment by Application, split into

  • Hospitals
  • Pharmacies
  • Online Pharmacies

Market segment by Regions/Countries, this report covers

  • United States
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America

The study objectives of this report are:

  • To analyze global Immuno-Oncology status, future forecast, growth opportunity, key market and key players.
  • To present the Immuno-Oncology development in United States, Europe and China.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Immuno-Oncology are as follows:

  • History Year: 2014-2018
  • Base Year: 2018
  • Estimated Year: 2019
  • Forecast Year 2019 to 2025

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

Table of Contents

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Immuno-Oncology Market Size Growth Rate by Type (2014-2025)
    • 1.4.2 Immune Checkpoint Inhibitors
    • 1.4.3 Monoclonal Antibodies
    • 1.4.4 Cytokine-Based Immunotherapy
    • 1.4.5 Cancer Vaccines
    • 1.4.6 CAR-T Cell Therapy
  • 1.5 Market by Application
    • 1.5.1 Global Immuno-Oncology Market Share by Application (2014-2025)
    • 1.5.2 Hospitals
    • 1.5.3 Pharmacies
    • 1.5.4 Online Pharmacies
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Immuno-Oncology Market Size
  • 2.2 Immuno-Oncology Growth Trends by Regions
    • 2.2.1 Immuno-Oncology Market Size by Regions (2014-2025)
    • 2.2.2 Immuno-Oncology Market Share by Regions (2014-2019)
  • 2.3 Industry Trends
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Opportunities

3 Market Share by Key Players

  • 3.1 Immuno-Oncology Market Size by Manufacturers
    • 3.1.1 Global Immuno-Oncology Revenue by Manufacturers (2014-2019)
    • 3.1.2 Global Immuno-Oncology Revenue Market Share by Manufacturers (2014-2019)
    • 3.1.3 Global Immuno-Oncology Market Concentration Ratio (CR5 and HHI)
  • 3.2 Immuno-Oncology Key Players Head office and Area Served
  • 3.3 Key Players Immuno-Oncology Product/Solution/Service
  • 3.4 Date of Enter into Immuno-Oncology Market
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

  • 4.1 Global Immuno-Oncology Market Size by Type (2014-2019)
  • 4.2 Global Immuno-Oncology Market Size by Application (2014-2019)

5 United States

  • 5.1 United States Immuno-Oncology Market Size (2014-2019)
  • 5.2 Immuno-Oncology Key Players in United States
  • 5.3 United States Immuno-Oncology Market Size by Type
  • 5.4 United States Immuno-Oncology Market Size by Application

6 Europe

  • 6.1 Europe Immuno-Oncology Market Size (2014-2019)
  • 6.2 Immuno-Oncology Key Players in Europe
  • 6.3 Europe Immuno-Oncology Market Size by Type
  • 6.4 Europe Immuno-Oncology Market Size by Application

7 China

  • 7.1 China Immuno-Oncology Market Size (2014-2019)
  • 7.2 Immuno-Oncology Key Players in China
  • 7.3 China Immuno-Oncology Market Size by Type
  • 7.4 China Immuno-Oncology Market Size by Application

8 Japan

  • 8.1 Japan Immuno-Oncology Market Size (2014-2019)
  • 8.2 Immuno-Oncology Key Players in Japan
  • 8.3 Japan Immuno-Oncology Market Size by Type
  • 8.4 Japan Immuno-Oncology Market Size by Application

9 Southeast Asia

  • 9.1 Southeast Asia Immuno-Oncology Market Size (2014-2019)
  • 9.2 Immuno-Oncology Key Players in Southeast Asia
  • 9.3 Southeast Asia Immuno-Oncology Market Size by Type
  • 9.4 Southeast Asia Immuno-Oncology Market Size by Application

10 India

  • 10.1 India Immuno-Oncology Market Size (2014-2019)
  • 10.2 Immuno-Oncology Key Players in India
  • 10.3 India Immuno-Oncology Market Size by Type
  • 10.4 India Immuno-Oncology Market Size by Application

11 Central & South America

  • 11.1 Central & South America Immuno-Oncology Market Size (2014-2019)
  • 11.2 Immuno-Oncology Key Players in Central & South America
  • 11.3 Central & South America Immuno-Oncology Market Size by Type
  • 11.4 Central & South America Immuno-Oncology Market Size by Application

12 International Players Profiles

  • 12.1 Amgen, Inc
    • 12.1.1 Amgen, Inc Company Details
    • 12.1.2 Company Description and Business Overview
    • 12.1.3 Immuno-Oncology Introduction
    • 12.1.4 Amgen, Inc Revenue in Immuno-Oncology Business (2014-2019)
    • 12.1.5 Amgen, Inc Recent Development
  • 12.2 AstraZeneca, Plc
    • 12.2.1 AstraZeneca, Plc Company Details
    • 12.2.2 Company Description and Business Overview
    • 12.2.3 Immuno-Oncology Introduction
    • 12.2.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2014-2019)
    • 12.2.5 AstraZeneca, Plc Recent Development
  • 12.3 Bristol-Myers Squibb
    • 12.3.1 Bristol-Myers Squibb Company Details
    • 12.3.2 Company Description and Business Overview
    • 12.3.3 Immuno-Oncology Introduction
    • 12.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2014-2019)
    • 12.3.5 Bristol-Myers Squibb Recent Development
  • 12.4 Celgene Corporation
    • 12.4.1 Celgene Corporation Company Details
    • 12.4.2 Company Description and Business Overview
    • 12.4.3 Immuno-Oncology Introduction
    • 12.4.4 Celgene Corporation Revenue in Immuno-Oncology Business (2014-2019)
    • 12.4.5 Celgene Corporation Recent Development
  • 12.5 Eli Lilly and Company
    • 12.5.1 Eli Lilly and Company Company Details
    • 12.5.2 Company Description and Business Overview
    • 12.5.3 Immuno-Oncology Introduction
    • 12.5.4 Eli Lilly and Company Revenue in Immuno-Oncology Business (2014-2019)
    • 12.5.5 Eli Lilly and Company Recent Development
  • 12.6 Merck & Co.
    • 12.6.1 Merck & Co. Company Details
    • 12.6.2 Company Description and Business Overview
    • 12.6.3 Immuno-Oncology Introduction
    • 12.6.4 Merck & Co. Revenue in Immuno-Oncology Business (2014-2019)
    • 12.6.5 Merck & Co. Recent Development
  • 12.7 Hoffmann-La Roche AG
    • 12.7.1 Hoffmann-La Roche AG Company Details
    • 12.7.2 Company Description and Business Overview
    • 12.7.3 Immuno-Oncology Introduction
    • 12.7.4 Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2014-2019)
    • 12.7.5 Hoffmann-La Roche AG Recent Development
  • 12.8 Johnson & Johnson
    • 12.8.1 Johnson & Johnson Company Details
    • 12.8.2 Company Description and Business Overview
    • 12.8.3 Immuno-Oncology Introduction
    • 12.8.4 Johnson & Johnson Revenue in Immuno-Oncology Business (2014-2019)
    • 12.8.5 Johnson & Johnson Recent Development
  • 12.9 Novartis International AG
    • 12.9.1 Novartis International AG Company Details
    • 12.9.2 Company Description and Business Overview
    • 12.9.3 Immuno-Oncology Introduction
    • 12.9.4 Novartis International AG Revenue in Immuno-Oncology Business (2014-2019)
    • 12.9.5 Novartis International AG Recent Development
  • 12.10 AbbVie
    • 12.10.1 AbbVie Company Details
    • 12.10.2 Company Description and Business Overview
    • 12.10.3 Immuno-Oncology Introduction
    • 12.10.4 AbbVie Revenue in Immuno-Oncology Business (2014-2019)
    • 12.10.5 AbbVie Recent Development
  • 12.11 Pfizer Inc.
  • 12.12 Sanofi S.A.
  • 12.13 EMD Serono
  • 12.14 Gilead Sciences Inc.
  • 12.15 Prometheus Therapeutics & Diagnostics
  • 12.16 Aduro BioTech
  • 12.17 Galena Biopharma
  • 12.18 Bavarian Nordic
  • 12.19 Celldex Therapeutics
  • 12.20 ImmunoCellular Therapeutics
  • 12.21 Incyte

13 Market Forecast 2019-2025

  • 13.1 Market Size Forecast by Regions
  • 13.2 United States
  • 13.3 Europe
  • 13.4 China
  • 13.5 Japan
  • 13.6 Southeast Asia
  • 13.7 India
  • 13.8 Central & South America
  • 13.9 Market Size Forecast by Product (2019-2025)
  • 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
      • 15.1.1.1 Research Programs/Design
      • 15.1.1.2 Market Size Estimation
      • 12.1.1.3 Market Breakdown and Data Triangulation
    • 15.1.2 Data Source
      • 15.1.2.1 Secondary Sources
      • 15.1.2.2 Primary Sources
  • 15.2 Disclaimer
  • 15.3 Author Details

List of Tables and Figures

  • Table Immuno-Oncology Key Market Segments
  • Table Key Players Immuno-Oncology Covered
  • Table Global Immuno-Oncology Market Size Growth Rate by Type 2014-2025 (Million US$)
  • Figure Global Immuno-Oncology Market Size Market Share by Type 2014-2025
  • Figure Immune Checkpoint Inhibitors Figures
  • Table Key Players of Immune Checkpoint Inhibitors
  • Figure Monoclonal Antibodies Figures
  • Table Key Players of Monoclonal Antibodies
  • Figure Cytokine-Based Immunotherapy Figures
  • Table Key Players of Cytokine-Based Immunotherapy
  • Figure Cancer Vaccines Figures
  • Table Key Players of Cancer Vaccines
  • Figure CAR-T Cell Therapy Figures
  • Table Key Players of CAR-T Cell Therapy
  • Table Global Immuno-Oncology Market Size Growth by Application 2014-2025 (Million US$)
  • Figure Hospitals Case Studies
  • Figure Pharmacies Case Studies
  • Figure Online Pharmacies Case Studies
  • Figure Immuno-Oncology Report Years Considered
  • Table Global Immuno-Oncology Market Size 2014-2025 (Million US$)
  • Figure Global Immuno-Oncology Market Size and Growth Rate 2014-2025 (Million US$)
  • Table Global Immuno-Oncology Market Size by Regions 2014-2025 (Million US$)
  • Table Global Immuno-Oncology Market Size by Regions 2014-2019 (Million US$)
  • Table Global Immuno-Oncology Market Share by Regions 2014-2019
  • Figure Global Immuno-Oncology Market Share by Regions 2014-2019
  • Figure Global Immuno-Oncology Market Share by Regions 2019
  • Table Market Top Trends
  • Table Global Immuno-Oncology Revenue by Manufacturers (2014-2019) (Million US$)
  • Table Global Immuno-Oncology Market Share by Manufacturers (2014-2019)
  • Figure Global Immuno-Oncology Market Share by Manufacturers in 2018
  • Table Global Immuno-Oncology Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table Key Players Head office and Area Served
  • Table Key Players Immuno-Oncology Product/Solution/Service
  • Table Date of Enter into Immuno-Oncology Market
  • Table Mergers & Acquisitions, Expansion Plans
  • Table Global Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table Global Immuno-Oncology Market Size Share by Type (2014-2019)
  • Figure Global Immuno-Oncology Market Size Market Share by Type (2014-2019)
  • Table Global Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table Global Immuno-Oncology Market Size Share by Application (2014-2019)
  • Figure Global Immuno-Oncology Market Size Market Share by Application (2014-2019)
  • Figure Global Immuno-Oncology Revenue Market Share by Application in 2018
  • Figure United States Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table United States Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table United States Key Players Immuno-Oncology Market Share (2018-2019)
  • Table United States Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table United States Immuno-Oncology Market Share by Type (2014-2019)
  • Table United States Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table United States Immuno-Oncology Market Share by Application (2014-2019)
  • Figure Europe Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table Europe Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table Europe Key Players Immuno-Oncology Market Share (2018-2019)
  • Table Europe Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table Europe Immuno-Oncology Market Share by Type (2014-2019)
  • Table Europe Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table Europe Immuno-Oncology Market Share by Application (2014-2019)
  • Figure China Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table China Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table China Key Players Immuno-Oncology Market Share (2018-2019)
  • Table China Immuno-Oncology Market Size by Type (2014-20189) (Million US$)
  • Table China Immuno-Oncology Market Share by Type (2014-2019)
  • Table China Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table China Immuno-Oncology Market Share by Application (2014-2019)
  • Figure Japan Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table Japan Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table Japan Key Players Immuno-Oncology Market Share (2018-2019)
  • Table Japan Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table Japan Immuno-Oncology Market Share by Type (2014-2019)
  • Table Japan Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table Japan Immuno-Oncology Market Share by Application (2014-2019)
  • Figure Southeast Asia Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table Southeast Asia Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table Southeast Asia Key Players Immuno-Oncology Market Share (2018-2019)
  • Table Southeast Asia Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table Southeast Asia Immuno-Oncology Market Share by Type (2014-2019)
  • Table Southeast Asia Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table Southeast Asia Immuno-Oncology Market Share by Application (2014-2019)
  • Figure India Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table India Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table India Key Players Immuno-Oncology Market Share (2018-2019)
  • Table India Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table India Immuno-Oncology Market Share by Type (2014-2019)
  • Table India Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table India Immuno-Oncology Market Share by Application (2014-2019)
  • Figure Central & South America Immuno-Oncology Market Size 2014-2019 (Million US$)
  • Table Central & South America Key Players Immuno-Oncology Revenue (2018-2019) (Million US$)
  • Table Central & South America Key Players Immuno-Oncology Market Share (2018-2019)
  • Table Central & South America Immuno-Oncology Market Size by Type (2014-2019) (Million US$)
  • Table Central & South America Immuno-Oncology Market Share by Type (2014-2019)
  • Table Central & South America Immuno-Oncology Market Size by Application (2014-2019) (Million US$)
  • Table Central & South America Immuno-Oncology Market Share by Application (2014-2019)
  • Table Amgen, Inc Company Details
  • Table Amgen, Inc Revenue in Immuno-Oncology Business (2014-2019) (Million US$)
  • Figure Amgen, Inc Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Amgen, Inc Recent Development
  • Table AstraZeneca, Plc Company Details
  • Table AstraZeneca, Plc Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure AstraZeneca, Plc Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table AstraZeneca, Plc Recent Development
  • Table Bristol-Myers Squibb Company Details
  • Table Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Bristol-Myers Squibb Recent Development
  • Table Celgene Corporation Company Details
  • Table Celgene Corporation Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Celgene Corporation Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Celgene Corporation Recent Development
  • Table Eli Lilly and Company Company Details
  • Table Eli Lilly and Company Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Eli Lilly and Company Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Eli Lilly and Company Recent Development
  • Table Merck & Co. Company Details
  • Table Merck & Co. Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Merck & Co. Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Merck & Co. Recent Development
  • Table Hoffmann-La Roche AG Company Details
  • Table Hoffmann-La Roche AG Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Hoffmann-La Roche AG Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Hoffmann-La Roche AG Recent Development
  • Table Johnson & Johnson Company Details
  • Table Johnson & Johnson Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Johnson & Johnson Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Johnson & Johnson Recent Development
  • Table Novartis International AG Company Details
  • Table Novartis International AG Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure Novartis International AG Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table Novartis International AG Recent Development
  • Table AbbVie Company Details
  • Table AbbVie Revenue in Immuno-Oncology Business (2014-2019)(Million US$)
  • Figure AbbVie Revenue Growth Rate in Immuno-Oncology Business (2014-2019)
  • Table AbbVie Recent Development
  • Table Pfizer Inc. Company Details
  • Table Sanofi S.A. Company Details
  • Table EMD Serono Company Details
  • Table Gilead Sciences Inc. Company Details
  • Table Prometheus Therapeutics & Diagnostics Company Details
  • Table Aduro BioTech Company Details
  • Table Galena Biopharma Company Details
  • Table Bavarian Nordic Company Details
  • Table Celldex Therapeutics Company Details
  • Table ImmunoCellular Therapeutics Company Details
  • Table Incyte Company Details
  • Table Global Immuno-Oncology Market Size by Regions (Million US$) 2019-2025
  • Figure Global Immuno-Oncology Market Size Share by Regions (2019-2025)
  • Figure Global Immuno-Oncology Market Size Share by Regions in 2025
  • Figure United States Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Figure Europe Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Figure China Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Figure Japan Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Figure Southeast Asia Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Figure India Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Figure Central & South America Immuno-Oncology Market Size Forecast (2019-2025)(Million USD)
  • Table Global Immuno-Oncology Market Size by Product (2019-2025) (Million US$)
  • Figure Global Immuno-Oncology Market Size by Product (2019-2025)
  • Figure Global Immuno-Oncology Market Size by Product in 2025
  • Table Global Immuno-Oncology Market Size by Application (2019-2025) (Million US$)
  • Figure Global Immuno-Oncology Market Size by Application (2019-2025)
  • Figure Global Immuno-Oncology Market Size by Application in 2025
  • Table Research Programs/Design for This Report
  • Figure Bottom-up and Top-down Approaches for This Report
  • Figure Data Triangulation
  • Table Key Data Information from Secondary Sources
  • Table Key Data Information from Primary Sources
Back to Top